This invention relates to a wax composition comprising a plurality of fatty acid amide compounds having the Formula (I): ##STR00001##
where R.sup.1, R.sup.2, n.sub.1, n.sub.2, m.sub.1, and m.sub.2 are as described herein. This invention also relates to a wax composition comprising: a) one or more fatty acid amide compounds having the Formula (II): ##STR00002##
and b) one or more fatty acid amide compounds having the Formula (III): ##STR00003##
where R.sup.1, R.sup.2, n.sub.1, and n.sub.2 are as described herein. This invention also relates to a fatty acid amide compound having the Formula (I) and a process for preparing a compound of Formula (I).

The present invention provides a synthetic chemical method for preparing -hydroxylated polyunsaturated fatty acids (PUFAs) including 20-hydroxyeicosatetraenoic acid (20-HETE), 20-hydroxyeicosapentaenoic acid (20-HEPE), and 22-hydroxydocosahexaenoic acid (22-HDoHE) and a method of use thereof for treating cancer and macular degeneration.

The present invention provides a composite comestible product comprising distinct first and second components, wherein the first component has a total fat content comprising a randomly interesterified fat, the randomly interesterified fat having a saturated fat content of from 35 to 55 wt % by weight of the randomly interesterified fat, wherein the total fat content comprises from 20 to 50 wt % saturated fat and less than 3 wt % trans fatty acids by weight of the total fat content, and wherein the second component is a chocolate component comprising one or more sources of cocoa butter (CB) or cocoa butter equivalent (CBE).

The present invention provides a composition comprising 10-40 mass % of C.sub.8-30 linear alkanes, up to 20 mass % of C.sub.7-20 aromatic hydrocarbons, at least 90 mass % of which are monoaromatic, and no more than 1 mass % in total of oxygen-containing compounds; wherein the total amount of C.sub.8-30 alkanes in the composition is 50-95 mass %, and the total amount of C.sub.8-30 alkanes, C.sub.7-20 aromatic hydrocarbons and C.sub.8-30 cycloalkanes is at least 95 mass %; wherein the composition comprises 45-90 mass % in total of C.sub.8-30 cycloalkanes and C.sub.8-30 branched alkanes; and wherein the amounts are based on the mass of the composition. Also provided is a method of producing the composition comprising the step of hydroprocessing a biological feedstock using a catalyst and the step of fractionating the product of the hydroprocessing step.

The present invention provides a composition comprising 10-40 mass % of C.sub.8-30 linear alkanes, up to 20 mass % of C.sub.7-20 aromatic hydrocarbons, at least 90 mass % of which are monoaromatic, and no more than 1 mass % in total of oxygen-containing compounds; wherein the total amount of C.sub.8-30 alkanes in the composition is 50-95 mass %, and the total amount of C.sub.8-30 alkanes, C.sub.7-20 aromatic hydrocarbons and C.sub.8-30 cycloalkanes is at least 95 mass %; wherein the composition comprises 45-90 mass % in total of C.sub.8-30 cycloalkanes and C.sub.8-30 branched alkanes; and wherein the amounts are based on the mass of the composition. Also provided is a method of producing the composition comprising the step of hydroprocessing a biological feedstock using a catalyst and the step of fractionating the product of the hydroprocessing step.

The present invention provides a synthetic chemical method for preparing -hydroxylated polyunsaturated fatty acids (PUFAs) including 20-hydroxyeicosatetraenoic acid (20-HETE), 20-hydroxyeicosapentaenoic acid (20-HEPE), and 22-hydroxydocosahexaenoic acid (22-HDoHE) and a method of use thereof for treating cancer and macular degeneration.

The invention relates to a process for the hydrogenation of vegetable oils that selectively converts polyunsaturated fatty acids into mono-unsaturated fatty acids, and to the products obtained therefrom. Vegetable oils obtained by the process according to the invention have a particularly high content of monounsaturated fatty acids and are suitable for use as raw materials for the synthesis of chemical intermediates.

The invention relates to a process for the hydrogenation of vegetable oils that selectively converts polyunsaturated fatty acids into mono-unsaturated fatty acids, and to the products obtained therefrom. Vegetable oils obtained by the process according to the invention have a particularly high content of monounsaturated fatty acids and are suitable for use as raw materials for the synthesis of chemical intermediates.

This present invention generally relates to a process for manufacturing hydrogenated vegetable oil without any significant amount of trans fatty acids for food and feed industry using high voltage atmospheric cold plasma (HVACP) in the presence of a working gas, and in particular to a process for manufacturing hydrogenated vegetable oil that meet the FDA's criteria of GRAS (generally considered as safe). A product of this process is also within the scope of this disclosure.

This present invention generally relates to a process for manufacturing hydrogenated vegetable oil without any significant amount of trans fatty acids for food and feed industry using high voltage atmospheric cold plasma (HVACP) in the presence of a working gas, and in particular to a process for manufacturing hydrogenated vegetable oil that meet the FDA's criteria of GRAS (generally considered as safe). A product of this process is also within the scope of this disclosure.